| Income Statement |
| Total Revenue | 282.21M |
|
| Revenues (USD) | 282.21M |
| Cost of Revenue | 126.64M |
| Gross Profit | 155.57M |
| Operating Expenses | 90.64M |
| Research and Development Expense | 37.35M |
| Selling, General and Administrative Expense | 51.46M |
| Operating Income | 64.94M |
| Income Tax Expense | 19.98M |
| Net Income | 49.30M |
| Net Income Common Stock | 49.30M |
| Net Income Common Stock (USD) | 49.30M |
| Consolidated Income | 49.30M |
| Earnings per Basic Share | 0.83 |
| Earnings per Basic Share (USD) | 0.83 |
| Earnings per Diluted Share | 0.82 |
| Earning Before Interest & Taxes (EBIT) | 69.27M |
| Earning Before Interest & Taxes (USD) | 69.27M |
| Weighted Average Shares | 59.69M |
| Weighted Average Shares Diluted | 60.04M |
| Balance Sheet |
| Cash and Equivalents | 226.13M |
| Cash and Equivalents (USD) | 226.13M |
| Trade and Non-Trade Receivables | 227.11M |
| Current Assets | 515.82M |
| Property, Plant & Equipment Net | 72.70M |
| Total Assets | 740.54M |
| Total Debt | 55.69M |
| Current Liabilities | 467.40M |
| Debt Non-Current | 55.69M |
| Total Liabilities | 535.36M |
| Accumulated Retained Earnings (Deficit) | 240.58M |
| Accumulated Other Comprehensive Income | -35.99M |
| Shareholders Equity | 205.18M |
| Shareholders Equity (USD) | 205.18M |
| Assets Non-Current | 224.72M |
| Total Debt (USD) | 55.69M |
| Deferred Revenue | 355.91M |
| Goodwill and Intangible Assets | 62.24M |
| Liabilities Non-Current | 67.96M |
| Trade and Non-Trade Payables | 22.42M |
| Tax Assets | 43.76M |
| Tax Liabilities | 90.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.83M |
| Net Cash Flow from Financing | -179.39M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -102.61M |
| Capital Expenditure | -4.10M |
| Issuance (Purchase) of Equity Shares | -179.39M |
| Net Cash Flow from Investing | -4.10M |
| Net Cash Flow from Operations | 84.05M |
| Effect of Exchange Rate Changes on Cash | -3.17M |
| Share Based Compensation | 26.52M |